Cited 0 times in
Comparison of the Clinical Characteristics of Pediatric Poisoning Patients Who Visited Emergency Department Before and During the COVID-19 Pandemic
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, J | - |
dc.contributor.author | Jeon, W | - |
dc.contributor.author | Ko, Y | - |
dc.contributor.author | Choi, YJ | - |
dc.contributor.author | Yang, H | - |
dc.contributor.author | Lee, J | - |
dc.date.accessioned | 2023-02-21T04:33:33Z | - |
dc.date.available | 2023-02-21T04:33:33Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/24659 | - |
dc.description.abstract | BACKGROUND: We aimed to investigate changes in the clinical characteristics of pediatric poisoning patients who visited the emergency department (ED) before and during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: Poisoning cases below age 18 who visited the ED from January 2018 to December 2021 were retrospectively analysed. The study period was then divided into pre-COVID-19 and COVID-19 pandemic to compare poisoning patterns. RESULTS: During the study period, 86,153 visits to the pediatric ED had been recorded, with 625 patients being included the final analysis. During the COVID-19 period, the proportion of poisoned patients increased from 0.62% to 0.98%. The average age of the patients was higher in the COVID-19 period, with 53.4% of the cases being intentional (pre-COVID-19, 32.5%; P < 0.001). Moreover, 70.4% of poisoning cases during the COVID-19 period were caused by drugs (pre-COVID-19, 60.6%; P = 0.038). More patients underwent decontamination and laboratory investigation during the COVID-19 period than during the previous period (P = 0.007 and P < 0.001, respectively). The length of ED stay and the proportion of hospitalisation were significantly greater during the COVID-19 period. After analysing accidental poisoning cases, we found that antipyretics/nonsteroidal anti-inflammatory drugs and respiratory drugs were more common in the pre-COVID-19 group, whereas iron/vitamins, cardiovascular drugs and hormones were more common in the COVID-19 group. After analysing intentional poisoning cases, we found that 73.6% and 76.4% of the patients in the pre-COVID-19 and COVID-19 group had a history of psychiatric disease, respectively. Although no difference was observed in the frequency of previous first suicide attempts, 19.0% of the patients in the COVID-19 group attempted suicide more than three times. CONCLUSION: During the COVID-19 pandemic, intentional poisoning cases, especially in adolescence, increased and were treated more. Many of the patients with intentional poisoning had a history of mental illness or suicide in the past. Therefore, it seems that policy consideration for mentally vulnerable adolescents during this new pandemic period is necessary. | - |
dc.language.iso | en | - |
dc.subject.MESH | Adolescent | - |
dc.subject.MESH | Child | - |
dc.subject.MESH | COVID-19 | - |
dc.subject.MESH | Emergency Service, Hospital | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Pandemics | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Suicide, Attempted | - |
dc.title | Comparison of the Clinical Characteristics of Pediatric Poisoning Patients Who Visited Emergency Department Before and During the COVID-19 Pandemic | - |
dc.type | Article | - |
dc.identifier.pmid | 36472085 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723189 | - |
dc.subject.keyword | Covid-19 | - |
dc.subject.keyword | Emergency department | - |
dc.subject.keyword | Intentional poisoning | - |
dc.subject.keyword | Pediatric | - |
dc.subject.keyword | Poisoning | - |
dc.subject.keyword | Suicide | - |
dc.contributor.affiliatedAuthor | Ko, Y | - |
dc.contributor.affiliatedAuthor | Choi, YJ | - |
dc.contributor.affiliatedAuthor | Yang, H | - |
dc.contributor.affiliatedAuthor | Lee, J | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.3346/jkms.2022.37.e337 | - |
dc.citation.title | Journal of Korean medical science | - |
dc.citation.volume | 37 | - |
dc.citation.number | 47 | - |
dc.citation.date | 2022 | - |
dc.citation.startPage | e337 | - |
dc.citation.endPage | e337 | - |
dc.identifier.bibliographicCitation | Journal of Korean medical science, 37(47). : e337-e337, 2022 | - |
dc.identifier.eissn | 1598-6357 | - |
dc.relation.journalid | J010118934 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.